Unaudited Interim Financial Information

12 Months Ended

Dec. 31, 2012

Unaudited Interim Financial Information

16. Unaudited Interim Financial Information

2012	1st Qtr		2nd Qtr		3rd Qtr		4th Qtr		Year
(dollars in millions except per share amounts)
Net sales	$	730.0	$	742.6	$	722.9	$	762.6	$	2,958.1
Cost of goods sold		279.4		285.7		272.6		287.6		1,125.3
Income from operations before income taxes		191.4		185.5		178.2		177.3		732.4
Net income attributable to common shareholders		138.7		133.9		129.3		128.2		530.1
Basic earnings per share available to common shareholders		1.62		1.56		1.52		1.54		6.24
Diluted earnings per share available to common shareholders		1.60		1.54		1.50		1.52		6.16

For the second quarter 2012, other (income) expense, net, included asset impairments of $9.0 million and a reversal of $1.6 million of restructuring costs. The income tax provision increased $1.1 million due to a write-down of a tax receivable in a foreign jurisdiction. These items decreased net income attributable to common shareholders by $5.8 million after tax, or $0.07 diluted earnings per share available to common shareholders.

For the third quarter 2012, research and development expense included acquisition-related items consisting of an IPR&D charge and purchase accounting adjustments of $2.4 million. Other (income) expense, net, included asset impairments of $13.2 million. These items decreased net income attributable to common shareholders by $10.4 million after tax, or $0.12 diluted earnings per share available to common shareholders.

For the fourth quarter 2012, research and development expense included acquisition-related items consisting of an IPR&D charge and purchase accounting adjustments of $1.9 million. Other (income) expense, net, included a restructuring charge of $19.0 million. This item decreased net income attributable to common shareholders by $14.8 million after tax, or $0.17 diluted earnings per share available to common shareholders.

2011	1st Qtr		2nd Qtr			3rd Qtr		4th Qtr		Year
(dollars in millions except per share amounts)
Net sales	$	700.3	$	725.0		$	719.2	$	751.9	$	2,896.4
Cost of goods sold		264.8		275.5			274.9		282.1		1,097.3
Income from operations before income taxes		184.0		2.7			182.1		142.0		510.8
Net income (loss) attributable to common shareholders		131.9		(47.8	)		130.1		113.8		328.0
Basic earnings (loss) per share available to common shareholders(A)		1.52		(0.55	)		1.48		1.31		3.75
Diluted earnings (loss) per share available to common shareholders(A)		1.49		(0.55	)(B)		1.46		1.30		3.69

^(A) Total per share amounts may not add due to rounding.

^(B)  Common share equivalents primarily from share-based compensation plans were not included in the computation of diluted weighted average shares outstanding because their effect would have been antidilutive.

For the first quarter 2011, research and development expense included an acquisition-related item consisting of an IPR&D charge of $3.0 million. This item decreased net income attributable to common shareholders by $1.9 million after tax, or $0.02 diluted earnings per share available to common shareholders.

For the second quarter 2011, other (income) expense, net, included charges for legal settlements and commitments of $195.5 million and a reversal of $1.1 million of restructuring costs. These items increased net loss attributable to common shareholders by $188.7 million after tax, or $2.09 diluted loss per share available to common shareholders.

For the third quarter 2011, other (income) expense, net, included a net restructuring charge of $10.0 million and a charge for the impairment of Greek bonds of $7.0 million. The income tax provision decreased $1.1 million due to an audit settlement. These items decreased net income attributable to common shareholders by $12.6 million after tax, or $0.14 diluted earnings per share available to common shareholders.

For the fourth quarter 2011, marketing, selling and administrative expenses included acquisition-related items consisting of transaction costs of $3.8 million. Other (income) expense, net, included a charge for a legal settlement of $51.0 million, acquisition-related integration costs of $4.1 million, a charge for the impairment of Greek bonds of $4.5 million, and a net reversal of $1.1 million of restructuring costs. The income tax provision decreased $16.5 million due to audit settlements. These items decreased net income attributable to common shareholders by $34.8 million after tax or $0.40 diluted earnings per share available to common shareholders.